PacBio Announces Appointment of David Meline to Board of Directors
MENLO PARK, Calif., Oct. 16, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Meline to its Board of Directors, effective October 13, 2023. Mr. Meline was most recently the Chief Financial Officer of Moderna, Inc., a global biotechnology and pharmaceutical leader.
- MENLO PARK, Calif., Oct. 16, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Meline to its Board of Directors, effective October 13, 2023.
- Mr. Meline was most recently the Chief Financial Officer of Moderna, Inc., a global biotechnology and pharmaceutical leader.
- Mr. Meline will join the board of directors of HP Inc. effective November 1, 2023.
- "I am thrilled to join the PacBio Board at this pivotal stage," said Mr. Meline.